chr6-3225480-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_178012.5(TUBB2B):c.609C>T(p.Asp203Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,612,216 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0041 ( 4 hom., cov: 30)
Exomes 𝑓: 0.0040 ( 30 hom. )
Consequence
TUBB2B
NM_178012.5 synonymous
NM_178012.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.993
Genes affected
TUBB2B (HGNC:30829): (tubulin beta 2B class IIb) The protein encoded by this gene is a beta isoform of tubulin, which binds GTP and is a major component of microtubules. This gene is highly similar to TUBB2A and TUBB2C. Defects in this gene are a cause of asymmetric polymicrogyria. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 6-3225480-G-A is Benign according to our data. Variant chr6-3225480-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 137855.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-3225480-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.993 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0041 (623/152104) while in subpopulation NFE AF= 0.00524 (356/67924). AF 95% confidence interval is 0.00479. There are 4 homozygotes in gnomad4. There are 291 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 623 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB2B | NM_178012.5 | c.609C>T | p.Asp203Asp | synonymous_variant | 4/4 | ENST00000259818.8 | NP_821080.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00409 AC: 621AN: 151986Hom.: 4 Cov.: 30
GnomAD3 genomes
AF:
AC:
621
AN:
151986
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000906 AC: 224AN: 247170Hom.: 2 AF XY: 0.000805 AC XY: 108AN XY: 134230
GnomAD3 exomes
AF:
AC:
224
AN:
247170
Hom.:
AF XY:
AC XY:
108
AN XY:
134230
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00403 AC: 5880AN: 1460112Hom.: 30 Cov.: 34 AF XY: 0.00413 AC XY: 2999AN XY: 726380
GnomAD4 exome
AF:
AC:
5880
AN:
1460112
Hom.:
Cov.:
34
AF XY:
AC XY:
2999
AN XY:
726380
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00410 AC: 623AN: 152104Hom.: 4 Cov.: 30 AF XY: 0.00391 AC XY: 291AN XY: 74366
GnomAD4 genome
AF:
AC:
623
AN:
152104
Hom.:
Cov.:
30
AF XY:
AC XY:
291
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 23, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | TUBB2B: BP4, BP7, BS1, BS2 - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 13, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 01, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Complex cortical dysplasia with other brain malformations 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 21, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at